Administration of recombinant Gal-1 or co-culture with Gal-1-expressing cells (e.g., tumor cells and trophoblasts) leads to the expansion of classical FOXP3+ CD25+ Tregs as well [102]. The gene discussed is FOXP3; the disease is neoplasm.